Vaso Corporation (VASO)
OTCMKTS · Delayed Price · Currency is USD
0.1152
+0.0001 (0.09%)
Oct 16, 2025, 2:47 PM EDT
Vaso Corporation Market Cap
Vaso Corporation has a market cap or net worth of $20.25 million as of October 16, 2025. Its market cap has decreased by -39.14% in one year.
Market Cap
20.25M
Enterprise Value
-9.37M
Revenue
87.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since June 15, 1992, Vaso Corporation's market cap has decreased from 36.04M to 20.25M, a decrease of -43.82%. That is a compound annual growth rate of -1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 20.23M | -3.89% |
| Dec 31, 2024 | 21.05M | -60.64% |
| Dec 29, 2023 | 53.47M | 85.05% |
| Dec 30, 2022 | 28.90M | 202.47% |
| Dec 31, 2021 | 9.55M | -38.56% |
| Dec 31, 2020 | 15.55M | 202.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |